A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users.
NCT Number: NCT06532357
Status: COMPLETED
Study Type: OBSERVATIONAL
Conditions: Migraine
Sponsor: Pfizer
Sex: ALL
Age: ADULT, OLDER_ADULT
Enrollment: 1
Study Design: Observational Model: |Time Perspective: p
Start Date: 2024-06-09
Completion Date: 2024-06-10
Locations: Pfizer, New York, New York, 10001, United States

Summary:
The purpose of this study is to collect information of the US users from the Migraine Buddy app between 20 October 2023 and 20 May 2024. Patients who used Nurtec and/or triptans as an acute treatment for migraine, with or without a background of preventive treatment (anti-CGRP, Botox or oral migraine preventive medications) and completed a survey were eligible for this study. Acute treatment is a short-term treatment. The aim of this retrospective analysis was to learn about the user´s satisfaction with Nurtec or the triptan. The level of satisfaction with Nurtec will be compared to the level of satisfaction with triptans. The benefit of this study is the real-life setting of the information collected. This means that the users were using the Migraine Buddy app for tracking their migraines in real life.

Primary Outcome Measures: To evaluate satisfaction in terms of pain intensity after using Nurtec or triptans, How does satisfaction with pain intensity compare between adults diagnosed with migraine who are using Nurtec or triptans as an acute treatment for migraine? Satisfaction is measured using a questionnaire. This questionnaire was developed internally specifically for this study and asked the level of satisfaction with their treatment on a 7-levels Lickert scale. (1 = extremely dissatisfied to 7 = extremely satisfied). Based on their responses, the respondents will be stratified into those who were dissatisfied (reporting 1 = extremely dissatisfied to 3 = somewhat dissatisfied), neutral (4=neither dissatisfied nor satisfied) or satisfied (reporting 5 = somewhat satisfied to 7 = extremely satisfied) with the treatment., Up to 7 months|To evaluate the satisfaction regarding the attack duration after using Nurtec or triptans, How does satisfaction with attack duration compare between adults diagnosed with migraine who are using Nurtec or triptans as an acute treatment for migraine? Satisfaction is measured using a questionnaire. This questionnaire was developed internally specifically for this study and asked the level of satisfaction with their treatment on a 7-levels Lickert scale. (1 = extremely dissatisfied to 7 = extremely satisfied). Based on their responses, the respondents will be stratified into those who were dissatisfied (reporting 1 = extremely dissatisfied to 3 = somewhat dissatisfied), neutral (4=neither dissatisfied nor satisfied) or satisfied (reporting 5 = somewhat satisfied to 7 = extremely satisfied) with the treatment, Up to 7 months|Evaluation of satisfaction with regard to the speed of action after using Nurtec or triptans, How does satisfaction with speed of action compare between adults diagnosed with migraine who are using Nurtec or triptans as an acute treatment for migraine? Satisfaction is measured using a questionnaire. This questionnaire was developed internally specifically for this study and asked the level of satisfaction with their treatment on a 7-levels Lickert scale. (1 = extremely dissatisfied to 7 = extremely satisfied). Based on their responses, the respondents will be stratified into those who were dissatisfied (reporting 1 = extremely dissatisfied to 3 = somewhat dissatisfied), neutral (4=neither dissatisfied nor satisfied) or satisfied (reporting 5 = somewhat satisfied to 7 = extremely satisfied) with the treatment, Up to 7 months|To evaluate the satisfaction regarding the migraine-induced cognitive impact after using Nurtec or triptans, How does satisfaction with migraine-induced cognitive impact compare between adults diagnosed with migraine who are using Nurtec or triptans as an acute treatment for migraine? Satisfaction is measured using a questionnaire. This questionnaire was developed internally specifically for this study and asked the level of satisfaction with their treatment on a 7-levels Lickert scale. (1 = extremely dissatisfied to 7 = extremely satisfied). Based on their responses, the respondents will be stratified into those who were dissatisfied (reporting 1 = extremely dissatisfied to 3 = somewhat dissatisfied), neutral (4=neither dissatisfied nor satisfied) or satisfied (reporting 5 = somewhat satisfied to 7 = extremely satisfied) with the treatment, Up to 7 months|To assess the satisfaction with regard to the tolarability after using Nurtec or triptans, How does satisfaction with tolerability compare between adults diagnosed with migraine who are using Nurtec or triptans as an acute treatment for migraine? Satisfaction is measured using a questionnaire. This questionnaire was developed internally specifically for this study and asked the level of satisfaction with their treatment on a 7-levels Lickert scale. (1 = extremely dissatisfied to 7 = extremely satisfied). Based on their responses, the respondents will be stratified into those who were dissatisfied (reporting 1 = extremely dissatisfied to 3 = somewhat dissatisfied), neutral (4=neither dissatisfied nor satisfied) or satisfied (reporting 5 = somewhat satisfied to 7 = extremely satisfied) with the treatment, Up to 7 months|To assess the satisfaction about the relief of other symptoms after using Nurtec or triptans, How does satisfaction with relief of other symptoms compare between adults diagnosed with migraine who are using Nurtec or triptans as an acute treatment for migraine? Satisfaction is measured using a questionnaire. This questionnaire was developed internally specifically for this study and asked the level of satisfaction with their treatment on a 7-levels Lickert scale. (1 = extremely dissatisfied to 7 = extremely satisfied). Based on their responses, the respondents will be stratified into those who were dissatisfied (reporting 1 = extremely dissatisfied to 3 = somewhat dissatisfied), neutral (4=neither dissatisfied nor satisfied) or satisfied (reporting 5 = somewhat satisfied to 7 = extremely satisfied) with the treatment, Up to 7 months|To assess the holistic benefit of rimegepant as compared to triptans, particularly in relation to patients' satisfaction with regards to medication efficacy, tolerability, and migraine-induced cognitive impact, How do clinical characteristics (for e.g., migraine severity, current migraine prophylactic treatment use) impact patients' satisfaction with regards to medication efficacy, tolerability, and migraine-induced cognitive impact in those who are using Nurtec or triptans as an acute treatment for migraine. Satisfaction is measured using a questionnaire. This questionnaire was developed internally specifically for this study and asked the level of satisfaction with their treatment on a 7-levels Lickert scale. (1 = extremely dissatisfied to 7 = extremely satisfied). Based on their responses, the respondents will be stratified into those who were dissatisfied (reporting 1 = extremely dissatisfied to 3 = somewhat dissatisfied), neutral (4=neither dissatisfied nor satisfied) or satisfied (reporting 5 = somewhat satisfied to 7 = extremely satisfied) with the treatment, Up to 7 months